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Abstract
Background: Insulin-producing beta cells emerge during pancreas development in two sequential waves. Recently
described later-forming beta cells in zebrafish show high similarity to second wave mammalian beta cells in
developmental capacity. Loss-of-function studies in mouse and zebrafish demonstrated that the homeobox
transcription factors Pdx1 and Hb9 are both critical for pancreas and beta cell development and discrete stage-
specific requirements for these genes have been uncovered. Previously, exocrine and endocrine cell recovery was
shown to follow loss of pdx1 in zebrafish, but the progenitor cells and molecular mechanisms responsible have not
been clearly defined. In addition, interactions of pdx1 and hb9 in beta cell formation have not been addressed.
Results: To learn more about endocrine progenitor specification, we examined beta cell formation following
morpholino-mediated depletion of pdx1 and hb9. We find that after early beta cell reduction, recovery occurs
following loss of either pdx1 or hb9 function. Unexpectedly, simultaneous knockdown of both hb9 and pdx1 leads
to virtually complete and persistent beta cell deficiency. We used a NeuroD:EGFP transgenic line to examine
endocrine cell behavior in vivo and developed a novel live-imaging technique to document emergence and
migration of late-forming endocrine precursors in real time. Our data show that Notch-responsive progenitors for
late-arising endocrine cells are predominantly post mitotic and depend on pdx1. By contrast, early-arising
endocrine cells are specified and differentiate independent of pdx1.
Conclusions: The nearly complete beta cell deficiency after combined loss of hb9 and pdx1 suggests functional
cooperation, which we clarify as distinct roles in early and late endocrine cell formation. A novel imaging approach
permitted visualization of the emergence of late endocrine cells within developing embryos for the first time. We
demonstrate a pdx1-dependent progenitor population essential for the formation of duct-associated, second wave
endocrine cells. We further reveal an unexpectedly low mitotic activity in these progenitor cells, indicating that
they are set aside early in development.
Background
In the vertebrate pancreas, the increase in endocrine
cells during late and post-embryonic development is
caused by de novo progenitor differentiation and prolif-
eration of pre-existing endocrine cells [1]. In mice, the
majority of endocrine cells arise after embryonic day
12.5 (e12.5), from cells located in the branched epithe-
lium of the dorsal and ventral buds. These second wave
endocrine cells delaminate, migrate and cluster into
numerous islets [1,2]. In addition, early-forming, first
wave endocrine cells of unknown function appear before
epithelial branching at e9.5, but do not contribute to
mature islets [1]. Only recently, two waves of endocrine
cell development were also observed in zebrafish. Simi-
larly, cells with a mature gene expression profile only
form during the second wave, while the early cells do
not contribute to the later bulk of mature beta cells that
produce insulin at high levels [3].
The zebrafish pancreas arises from two progenitor
domains called the dorsal bud and ventral bud (DB and
VB, respectively), which have distinct differentiation
potentials [3,4]. The DB forms before 24 h post fertiliza-
tion (hpf), and consists of clustered early endocrine cells
called the principal islet. The VB arises from the gut
tube after 34 hpf, and these cells migrate to engulf the
principal islet [4,5]. Cells of the VB expand posteriorly
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crine cells, duct cells, and late arising (second wave)
endocrine cells. The ventral bud-derived ductal system
includes the attachment of the pancreas to the gut
(extrapancreatic duct (EPD)), and a branching network
in the expanding pancreatic tail (intrapancreatic duct
(IPD)). Late endocrine cells in zebrafish appear to origi-
nate from progenitors located in or adjacent to the duc-
tal system and contribute to expansion of the large
principal islet and also coalesce to form scattered smal-
ler secondary islets [5-8]. The emergence of late endo-
crine cells is considered analogous to the second wave
of endocrine cell differentiation in mammals [3,5,7].
Pancreas formation requires the function of a highly
conserved network of hierarchically expressed transcrip-
tion factors. Among them, Pdx1 and Hb9 (also called
Mnx1, Hlxb9) play key roles in pancreas and beta cell
development, as demonstrated by loss-of-function stu-
dies in mice [9,10]. Pdx1 is expressed throughout the
early pancreatic progenitor domain and is highly
expressed in mature beta cells. Pdx1 is not required for
the formation of first wave endocrine cells in mice
[11,12], but promotes second wave islet cell formation
[13,14]. Hb9 is expressed in a pattern overlapping with
Pdx1 in the early progenitors of the dorsal and ventral
buds [15]. After formation of pancreatic buds, Hb9 is
initially downregulated, and is activated again in differ-
entiating beta cells [16,17]. Loss of function Hb9
-/- mice
lack the dorsal bud, while ventral bud-derived islets are
smaller and have decreased numbers of incompletely
differentiated beta cells [16,17].
In zebrafish, morpholino knockdown approaches have
been used to study pancreatic function of hb9 and pdx1
[18-20]. Following morpholino-mediated pdx1 knock-
down, embryos showed delayed appearance of both exo-
crine and endocrine cells but displayed an almost
normal overall structure of the pancreas by 5 days post
fertilization (dpf) [18,19]. This reported recovery raises
questions about the requirement for pdx1 in progenitor
specification in zebrafish. hb9 is expressed broadly in
the endoderm during early somite stages and becomes
restricted to insulin-producing beta cells after onset of
endocrine differentiation at 15 hpf. Morpholino knock-
down analysis revealed a requirement for hb9 in early
beta cells [20]. The coexpression of pdx1 and hb9 in
beta cell progenitors suggests possible functional inter-
actions that have as yet not been assessed.
Differentiation of beta cells from progenitors is coor-
dinated with morphogenetic events that include delami-
nation of precursors from the ductal epithelium,
migration and islet assembly. Real-time imaging of this
dynamic process has not been previously achieved, as
direct observation is prevented by the deep interior loca-
tion of the pancreas. Such studies are feasible in
transparent zebrafish embryos. However, as visual access
to the developing gut is obstructed by the large yolk
cell, observation of endocrine cell emergence requires
the implementation of new imaging approaches.
Regulation of cell fate decisions in pancreatic endo-
crine progenitors involves Notch-regulated lateral inhibi-
tion that in mouse leads to increased Ngn3 expression in
a subset of cells within the nascent duct epithelium and
induction of proendocrine transcription factors such as
NeuroD [10,21,22]. Although the presumed zebrafish
ngn3 ortholog appears not to be functionally equivalent
to the mouse gene based on timing and localization of
expression [6,23], NeuroD is expressed in early precur-
sors that give rise to all endocrine cells in both mouse
and zebrafish [24-27]. In mouse, NeuroD was found to
have the capacity to drive endocrine differentiation in
pancreatic progenitors [28]. NeuroD expression is main-
tained in insulin-positive beta cells, while it is downre-
gulated in the other endocrine cell types [26].
In this study, we aimed to achieve a better under-
standing of beta cell progenitor specification and beha-
vior, and the dependence of these processes on pdx1
and hb9. After early reduction of beta cell numbers fol-
lowing morpholino-mediated depletion of hb9 or pdx1,
there is recovery of insulin expression at late stages. In
contrast, loss of both pdx1 and hb9 leads to an essen-
tially complete and persistent absence of beta cells. A
detailed analysis of endocrine precursors in wild-type
and morpholino-treated embryos using a NeuroD:EGFP
transgenic line revealed cooperative activity of hb9 and
pdx1 in establishing beta cell fate. Importantly, we
define a requirement for pdx1 in latent, duct-associated,
Notch-responsive progenitors responsible for the pro-
duction of second wave endocrine cells. These investiga-
tions were facilitated by the establishment of new
protocols for in vivo timelapse imaging that allow visua-
lization of delaminating and migrating endocrine pre-
cursors at high resolution.
Results
Beta cell loss following simultaneous knockdown of hb9
and pdx1
To determine how beta cell differentiation is affected
by the depletion of hb9 and pdx1,w ee x a m i n e dinsulin
(ins) expression over a time window of 5 days follow-
ing morpholino (MO) injection. Consistent with pre-
vious studies [18,20,29], hb9 and pdx1 MO-treated
embryos (morphants) analyzed by RNA in situ hybridi-
zation at 24 hpf had a marked decrease in ins expres-
sion (Figure 1C,E, compared to A). As seen in previous
analyses of pdx1 morphants, we now show that also in
hb9 morphants there was a substantial recovery of beta
cell development and ins expression by 5 dpf (Figure
1D,F,I).
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might cooperate in beta cell formation by coinjecting
embryos with hb9 and pdx1 morpholinos. This resulted
in an almost complete lack of ins expression at 24 hpf
(Figure 1G). This phenotype persisted, and at 5 dpf and
9d p f ,hb9/pdx1 morphants showed virtually no ins
expression (at 5 dpf 92% < 5 ins cells, n = 64; Figure
1H,I and at 9 dpf 93% < 5 ins cells, n = 14).
To exclude that pancreatic development is globally
disrupted in the double morphant, we examined expres-
sion of the exocrine marker carboxypeptidase A (Cpa).
As in the pdx1 morphants [18,19], hb9/pdx1 double
morphants show substantial development of exocrine
tissue at 4 dpf [see Additional file 1]. We also asked
whether pdx1 expression returns at later stages in mor-
pholino-injected embryos, by examining Pdx1 protein in
morphants. At 28 hpf and 48 hpf, Pdx1 expression is
entirely absent in the developing gut and pancreas of
pdx1 morphants (n = 13 [see Additional file 2A-F]). At
84 hpf during normal development, Pdx1 is strongly
expressed in cells of the islet with lower expression in
the exocrine pancreas (n = 8 [see Additional file 2G]),
while pdx1 morphants have low levels of Pdx1 protein
in exocrine pancreas and islet at this stage (n = 8 [see
Additional file 2H]). Thus, the morphant is not comple-
tely devoid of Pdx1 at late stages, but a low level of
expression is observed that allows rescue of exocrine
development and may account for the recovery of beta
cells.
Perturbed endocrine precursor formation in hb9/pdx1
knockdown embryos
Two mechanisms could account for the persistent
absence of beta cells in the hb9/pdx1 double morphants:
endocrine precursors may not be specified, or they may
fail to differentiate. To distinguish these possibilities we
analyzed green fluorescent protein (GFP) expression in
morphant embryos transgenic for TgBAC(NeuroD:EGFP)
nl1 [30]. These fish express enhanced green fluorescent
protein (EGFP) integrated into the NeuroD locus con-
tained in a bacterial artificial chromosome (BAC) by
homologous recombination. EGFP expression has been
reported to recapitulate NeuroD expression in the ner-
vous system. We now confirm that EGFP in TgBAC
(NeuroD:EGFP)nl1 embryos is first expressed in dis-
persed cells of the prepancreatic endoderm, which
migrate posteriorly and cluster to form the principal
islet by 24 hpf [see Additional files 3A and 4]. In a sub-
set of cells there is coexpression of endocrine hormones
[see Additional file 3B-G], recapitulating endogenous
NeuroD expression in islet cell precursors [25,27]. In
addition, the stability of EGFP allowed us to trace endo-
crine precursors during maturation after the downregu-
lation of the endogenous NeuroD.
Figure 1 ins mRNA expression in hb9 and pdx1 morphants. In
situ detection of ins mRNA in wild-type embryos (A,B), hb9
morphants (C,D), pdx1 morphants (E,F) and hb9/pdx1 double
morphants (G,H) at 24 h post fertilization (hpf) and 5 days post
fertilization (dpf). In hb9 and pdx1 morphants the number of ins
expressing cells is strongly reduced at 24 hpf as compared to
control embryos (A,C,E) but has substantially increased by 5 dpf (D,
F). (G,H) ins expression is missing in most double morphants (arrow
in H marks a single ins positive cell). Embryos are shown from
ventral (24 hpf) and lateral (5 dpf) view with anterior to the right.
Scale bars correspond to 20 μm (24 hpf) and 50 μm (5 dpf). (I)
Proportion of embryos showing > 5 Ins+ cells in control and
morphant embryos at 3 dpf and 5 dpf. Beta cells emerge between
3 dpf and 5 dpf in hb9 and pdx1 morphants, while there is
persistent absence in the hb9/pdx1 double morphant.
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pdx1 double morphants, we quantified pancreatic EGFP
+ c e l l sa t2 8h p f ,t h a ti s ,b e f o r et h ee m e r g e n c eo ft h e
ventral bud. At 28 hpf, double morphant embryos dis-
played a slightly reduced number of EGFP positive cells
as compared to controls (Figure 2A-C). In addition,
while EGFP+ cells in control embryos formed a compact
islet (n = 12), 50% of double morphants (n = 20)
showed loosely clustered or even widely separated GFP+
cells (Figure 2B), suggesting disrupted migration. Thus,
early endocrine cells were specified in these morphants,
albeit at reduced levels, and the residual endocrine cells
displayed defects in migration.
We next examined endocrine cell specification and
differentiation at 52 hpf, after the fusion of dorsal and
ventral buds. For this analysis we used embryos that
were double transgenic for TgBAC(NeuroD:EGFP)nl1
and Tg(ins:dsRed)m1018, enabling simultaneous visuali-
zation of progenitors and differentiated beta cells by
EGFP and dsRed, respectively, and in addition immu-
nostained the embryos for pancadherin to delineate gut
morphology (Figure 2D-F). In control embryos, the
Figure 2 Disrupted precursor specification and differentiation in hb9/pdx1 double morphants. (A,B) Projections of confocal image stacks
of native enhanced green fluorescent protein (EGFP) expression in control uninjected and in hb9/pdx1 morpholino injected TgBAC(NeuroD:EGFP)
nl1 embryos at 28 h post fertilization (hpf). In morphants, the clustering of EGFP labeled cells is disrupted (B) and the number of EGFP
expressing cells is reduced as compared to controls (C). By 52 hpf, NeuroD:EGFP cell numbers have increased in control embryos, but not
changed in the morphants ((C), *P < 0.05, ***P < 0.001 as determined by one-way analysis of variance (ANOVA) with Bonferroni’s post test). (D)
Schematic depicting overall gut morphology in 52 hpf embryos. EPD, extrapancreatic duct; IB, intestinal bulb; ISL, islet; SB, swim bladder. (E,F)
Confocal image projections of control uninjected (E) and hb9/pdx1 morpholino injected (F) TgBAC(NeuroD:EGFP)nl1;Tg(ins:dsRed)m1018 embryos at
52 hpf that were costained with antibodies against pan-cadherin (light blue) to outline epithelial structures. In control embryos, EGFP+ and EGFP
+/DsRed+ cells are mainly found in the islet. A rare EGFP+/DsRed+ cell is seen in a distal location (E, arrow). In double morphants, few to no
EGFP/DsRed-expressing cells can be detected and many EGFP+ cells are located at ectopic positions outside the developing gut epithelium (F).
Scale bar = 15 μM in all panels. All embryos are shown from ventral view, anterior to the left.
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between 28 hpf and 52 hpf (from 49 to 59 cells), but
these remained essentially constant in number in the
double morphants (average 39 cells; Figure 2C). Control
embryos had an average of 18 EGFP+/DsRed+ cells (n =
12), compared to double morphants that had few to no
DsRed+ cells (0 to 5 EGFP+/DsRed+ cells in 14/14
embryos) (Figure 2E,F). Furthermore, 47% (7/15) of dou-
ble morphant embryos showed clusters of EGFP
+/DsRed- cells located at a distance from the islet and
outside of the pancadherin stained gut epithelium (Fig-
ure 2F). Only one ectopic EGFP+ cell was seen in a sin-
gle control embryo (n = 12), and this cell also displayed
robust DsRed expression (Figure 2E). As DsRed takes 24
h to reach its half maximal fluorescence intensity [31],
this likely represents a rare displaced early rather than a
late beta cell. In summary, our analyses show that early
endocrine cell specification occurred in hb9/pdx1 double
morphants, and therefore a deficit in differentiation con-
tributes to the absence of ins-expressing cells at later
developmental stages. In addition, the formation of sec-
ond wave endocrine cells was disrupted, as the number
of NeuroD:EGFP cells did not increase after 28 hpf in
double morphants.
Loss of late forming NeuroD:EGFP cells in pdx1 morphants
We next analyzed NeuroD:EGFP cells in the islet of
morphant embryos at 3 dpf to determine if emergence
of second wave endocrine cells was delayed. Strik-
ingly, hb9/pdx1 double morphants displayed a persis-
tently low number of NeuroD:EGFP+ cells in the
principal islet, which even appears reduced relative to
earlier time points when only cells in the vicinity of
islet and extrapancreatic duct were counted (Figure
3E), and distal cells outside of the gut were not
included (Figure 2F).
Figure 3 Absence of ventral bud endocrine precursors in hb9/pdx1 and pdx1 morphant embryos. (A-D) Projections of confocal stacks
showing native fluorescence of 3 days post fertilization (dpf) TgBAC(NeuroD:EGFP)nl1; Tg(ins:dsRed)m1018 embryos. In uninjected control embryos
(A) and in hb9 morphants (C), enhanced green fluorescent protein (EGFP)+ cells are found in the islet and in smaller numbers also anterior to
the islet. In hb9/pdx1 double morphants (B) and pdx1 morphants (D), the number of islet-associated EGFP+ cells is strongly reduced and anterior
cells are missing. Few Ins:DsRed cells are present in pdx1 single morphants at 3 dpf (D), reflecting slow maturation of the DsRed fluorophore. (E)
Schematic of pancreas morphology at 3 dpf. The principal islet (Isl) at this stage is primarily dorsal bud derived. The ventral bud contributes new
NeuroD:EGFP cells (green circles), and generates exocrine pancreas (Exo) and extrapancreatic duct (EPD). IB, intestinal bulb; SB, swim bladder. Red
box delineates region included for quantitation of islet and newly emerging anterior endocrine cells. (F) Quantitation of pancreatic EGFP+ cells
(*P < 0.05, ***P < 0.001 with P values determined using one-way analysis of variance (ANOVA) with Bonferroni’s post test). (G) Quantitation of
anteriorly positioned EGFP+ cells in uninjected and morpholino injected embryos (error bars indicate standard deviation from the mean). Scale
bar = 10 μM.
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Page 5 of 14As Pdx1 is required in second wave endocrine pro-
genitors in mouse [13,14], we hypothesized that the
defect in late endocrine cell formation in double mor-
phants could be due to loss of pdx1 only. To assess the
individual contributions of pdx1 and hb9 to late endo-
crine cell formation, we quantitated NeuroD cell num-
ber in single morphants. At 3 dpf, EGFP+ cells in hb9
morphants were only slightly reduced relative to con-
trols, whereas in pdx1 morphants EGFP+ cells were
reduced by 50%, similar to the number observed in dou-
ble morphants (Figure 3A-D, F). In addition, control
embryos had EGFP+ cells located anterior to the islet
that were absent in double morphant embryos (Figure
3B). These cells occupied a position corresponding to
that of previously described late-arising endocrine cells
[4,32]. Strikingly, in pdx1 morphants but not in hb9
morphants, the anterior EGFP+ cells were also absent
(Figure 3C,D,G). Thus, the formation of late endocrine
cells specifically depends on pdx1, while early endocrine
cells were specified in the absence of pdx1 or hb9 [see
Additional file 5].
We also confirmed the persistent deficiency in new
endocrine cell formation by examining NeuroD:EGFP+
cells in the principal islet at 5 dpf in pdx1 morphants as
compared to control embryos, and found that NeuroD:
EGFP cells remained dramatically reduced [see Addi-
tional file 6A]. Furthermore, in pdx1 morphants (n = 7),
NeuroD:EGFP+ cells in the principal islet expressed
Pdx1 at low levels, as compared to robust expression in
controls [see Additional file 6C]. As ins-expressing cells
have increased by 3 dpf in pdx1 morphants (Figure 1I),
these beta cells originated from early specified, first
wave endocrine precursors that differentiate under con-
ditions of deficient Pdx1.
Extrapancreatic duct-associated NeuroD:EGFP cells are
migratory endocrine precursors
Second wave endocrine cells arise in association with
the developing ductal epithelium [10,32]. To precisely
localize the site at which pdx1-dependent anterior endo-
crine precursors arise, we immunostained TgBAC(Neu-
roD:EGFP)nl1;Tg(ins:dsRed)m1018 embryos at 3 dpf for
the duct marker 2F11. NeuroD-expressing cells were
found along the extrapancreatic duct (EPD), showed
coexpression of 2F11, and even appeared to be emerging
from the duct, with elongated processes characteristic of
delaminating and migrating cells (Figure 4A-D). In sup-
port of their identity as endocrine precursors, occasion-
ally such anterior NeuroD:EGFP cells expressed low
levels of Ins:DsRed and thus correspond to newly differ-
entiating beta cells (Figure 4C [see Additional file 7A]).
This was confirmed by insulin (Ins) antibody staining
[see Additional file 7C].
To document the emergence of these anterior endo-
crine cells, we developed a timelapse imaging technique
based on a method described for imaging the central
Figure 4 Anterior NeuroD:EGFP cells are migratory endocrine precursors. (A-D) Confocal sections of 3 days post fertilization (dpf) TgBAC
(NeuroD:EGFP)nl1; Tg(ins:dsRed)m1018 embryos colabeled with antibodies against green fluorescent protein (GFP) and duct marker 2F11 (in blue).
GFP+/2F11+ cells emerge from the duct (arrows), some with long projections typical of migrating cells (A, B, arrowhead). An individual cell that
has separated from the duct is weakly DsRed positive (C, arrowhead). (E) Confocal image projections from a timelapse sequence of a 3 dpf
TgBAC(NeuroD:EGFP)nl1;Tg(-8.0cldnb:lynEGFP)zf106 double transgenic embryo [see Additional file 8]. Membrane-linked enhanced green fluorescent
protein (EGFP) in Tg(-8.0cldnb:lynEGFP)zf106 embryos delineates the gut epithelium (blue outline = extrapancreatic duct (EPD)) while robust
cytoplasmic EGFP is present in NeuroD-expressing cells. Two NeuroD:EGFP cells (arrow) adjacent to the EPD migrate to the principal islet. All
embryos are shown from ventral view, with the anterior to the left. Scale bar = 15 μM.
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obstructs the deeply located pancreas, was paralyzed
and then extracted to establish a clear ventral view. This
procedure did not interfere with morphogenetic pro-
cesses. Using this novel method, we performed time-
lapse analysis of TgBAC(NeuroD:EGFP)nl1;Tg(-8.0cldnb:
lynEGFP)zf106 embryos at 3 dpf. In double transgenic
embryos, we recorded active delamination and clustering
of NeuroD:EGFP-positive cells adjacent to the extrapan-
creatic duct and migration of cells towards the principal
islet (Figure 4E [see Additional file 8]). Thus, our
method allows the visualization of dynamic cell beha-
viors in the context of the developing organ in real
time, and unambiguously demonstrates that new endo-
crine cells emerge from the duct epithelium and join
the principal islet.
Having established that second wave endocrine pre-
cursors emerge from the duct, we analyzed if their
absence in pdx1 morphants could be caused by a global
duct defect. At 72 hpf, duct development appeared nor-
mal in morphant embryos, as demonstrated by a normal
pattern of GFP-labeled duct cells in Tg(-3.5nkx2.2a:GFP)
ia3 transgenics [34] [see Additional file 7D-G]. Further-
more, Tg(-8.0cldnb:lynEGFP)zf106 embryos, in which
EGFP outlines membranes of the gut epithelium,
revealed normal cellular structure of the extrapancreatic
duct in pdx1 morphants as compared to controls [see
Additional file 7H]. We examined Pdx1 expression in
these embryos to address whether Pdx1 might have a
role within the duct as new endocrine cells emerge.
Pdx1 was highly expressed throughout the extrapancrea-
tic duct and proximal pancreas in control embryos,
while expression was very weak in pdx1 morphants [see
Additional file 7J]. This analysis indicates that depletion
of Pdx1 eliminated the ability of duct-associated cells to
give rise to endocrine precursors and argues against an
overall perturbation of the duct.
Post-mitotic origin of late emerging endocrine cells
We next asked the question whether late endocrine pre-
cursors arise from a mitotically active cell population.
We tested this by incubating control and pdx1 mor-
phant TgBAC(NeuroD:EGFP)nl1 embryos with nucleo-
tide analog EdU from 28 hpf to 76 hpf. This extended
incubation is expected to label dividing NeuroD+ endo-
crine precursors and dividing duct cells whose progeny
differentiated into NeuroD-expressing endocrine cells.
At 76 hpf, an average of 1.6 NeuroD:EGFP cells/embryo
in control embryos were EdU positive, and their number
in pdx1 morphants was not significantly different (1.4
NeuroD+/EdU+ cells/embryo (Figure 5I). In addition,
rare EdU+/NeuroD+ cells were found at the periphery
of the islet and distal to the islet, along the extrapan-
creatic duct in control embryos (Figure 5A-D). In sum-
mary, the NeuroD+/EdU+ double-labeled cells (average
1.6/embryo) cannot account for the appearance of ten
additional NeuroD-expressing cells that emerge in
embryos between 28 hpf and 76 hpf. Furthermore, most
Figure 5 Contribution of cell proliferation to late endocrine cell expansion. TgBAC(NeuroD:EGFP)nl1 embryos incubated with EdU from 28
to 76 h post fertilization (hpf), followed by EdU detection and green fluorescent protein (GFP) antibody staining. (A, E) Confocal projections and
single plane views (B-D, F-H), showing pancreatic region of control (A-D), and pdx1 morphant (E-H) embryos. (B-D) In control embryos, EdU/
NeuroD:enhanced green fluorescent protein (EGFP) colabeled cells are located at the periphery of the islet (red arrowhead) and in the region of
the extrapancreatic duct (EPD) (yellow arrowhead). Most islet cells are EdU- (C compared to D) and additional EdU-/NeuroD:EGFP+ cells are
found along the EPD (yellow arrows). (F-H) In pdx1 morphants, few EdU/NeuroD:EGFP colabeled cells are found within the islet (red arrowhead).
(I) Quantitation of EdU/NeuroD:EGFP cells per embryo in wild-type and pdx1 morphant embryos, showing mean and standard deviation. Scale
bar = 10 μm. NS, not significant; P > 0.05 as determined by unpaired t test.
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indicating that late endocrine cells appearing after 28
hpf arose from post-mitotic precursors. The pdx1 mor-
phant showed a similar low number of NeuroD+/EdU+
cells, which were all associated with the islet (Figure 5E-
H). Our data therefore suggest that late endocrine cells
emerge predominantly from a postmitotic cell type.
As proliferating cells were found directly adjacent to
the NeuroD:EGFP+ islet, we next used the Tg(ela3l:
EGFP)gz2 allele that labels exocrine pancreas [35] to
define their identity. Incubation of embryos from 28 to
76 hpf with EdU, followed by a 12-h chase, resulted in
extensive EdU labeling of the GFP+ exocrine pancreas
in control as well as in pdx1 morphant embryos [see
Additional file 9]. Therefore, ventral bud cells forming
the exocrine pancreas are highly proliferative during this
time period, and in pdx1 morphants no general prolif-
eration defect exists in the pancreas. We conclude that
beta cell recovery in pdx1 morphants is not accompa-
nied by activated proliferation in progenitors or differen-
tiated beta cells, but occurs through delayed precursor
differentiation.
Notch-responsive beta cell progenitors require pdx1
The zebrafish intrapancreatic duct is a ventral bud deri-
vative containing Notch-responsive endocrine progeni-
tors that begin to differentiate and assemble into
secondary islets after 3 dpf [5,7]. Blocking Notch signal-
ing after 3 dpf was previously shown to induce differen-
tiation of endocrine cells from duct-associated
progenitors [5,7]. We assessed whether the latent endo-
crine progenitors associated with the intrapancreatic
duct also arise in a pdx1-dependent manner.
To visualize the emergence of endocrine cells from
the intrapancreatic duct, we first used a Notch inhibitor
(N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine
t-butyl ester (DAPT)) to induce endocrine differentia-
tion and NeuroD:EGFP expression in latent progenitors.
In control experiments, treatment of TgBAC(NeuroD:
EGFP)nl1 embryos with DAPT from 3 to 5 dpf caused
an increase of cells in the principal islet and a fourfold
increase of GFP labeled cells within the pancreatic tail
as compared to vehicle-treated larvae (Figure 6A,E,F,K).
Overlapping expression of Ins and GFP following DAPT
treatment confirmed that newly-induced NeuroD:EGFP
cells in the pancreatic tail can differentiate into beta
cells (Figure 6B,D).
We next analyzed if these Notch-responsive cells were
present in pdx1 and hb9 morphants. We found virtually
no NeuroD:EGFP induction following DAPT treatment
in pdx1 morphants, while DAPT treatment in hb9 mor-
phants resulted in an increased number of NeuroD:
EGFP+ cells similar to controls (Figure 6G-K). Immu-
nostaining for duct marker 2F11 indicated that
Figure 6 Notch-responsive endocrine progenitors are absent in
pdx1 morphants. (A-D) Confocal image projections of Tg(NeuroD:
EGFP)nl1 embryos immunostained for green fluorescent protein
(GFP) and insulin. Optical sections that obscure the posterior
pancreatic tail have not been included. (E-J) Native enhanced green
fluorescent protein (EGFP) expression in the pancreas of living
TgBAC(NeuroD:EGFP)nl1 embryos at 5.5 days post fertilization (dpf),
with overlay of concurrently acquired brightfield image. Shown are
uninjected control embryos (A-D, E, F), hb9 morphants (G,H) and
pdx1 morphants (I,J) treated either with vehicle (dimethylsulfoxide
(DMSO)) (A,C,E,G,I) or 100 mM N-[N-(3,5-difluorophenacetyl)-L-alanyl]-
S-phenylglycine t-butyl ester (DAPT) (B,D,F,H,J) from 3 to 5 dpf.
DAPT treatment in control embryos leads to the induction of EGFP
expression in the pancreatic tail (A,B,E,F) and of Ins in individual of
these EGFP+ cells (B, D). In hb9 morphants the patterns of EGFP
expression in DMSO-treated and DAPT-treated embryos are similar
to that in control embryos (E-H), while pdx1 morphants show
Kimmel et al. BMC Biology 2011, 9:75
http://www.biomedcentral.com/1741-7007/9/75
Page 8 of 14intrapancreatic duct formation in pdx1 morphants was
comparable to controls [see Additional file 10A]. Over-
all, this indicates that Notch-responsive progenitors for
late-forming endocrine cells, that contribute new cells to
both principal islet expansion and secondary islet forma-
tion, require pdx1 (Figure 7).
Discussion
In this work, we determined that both hb9 and pdx1
have roles in early beta cell formation and that pdx1 is
distinctly required for second wave endocrine progenitor
specification, which generates endocrine cells that
expand the principal islet and form secondary islets.
Prior studies of pdx1 morphant zebrafish did not
quantitatively assess endocrine cell dynamics, and there-
fore the requirement for Pdx1 in formation of progeni-
tors for late endocrine cells went unrecognized. Our
new imaging approach allowed us to visualize the beha-
vior of emerging endocrine cells in real time and define
the source of the late endocrine progenitor cells. Specifi-
cally, we show that they originate and delaminate from
the ductal epithelium in a process that resembles forma-
tion of second wave endocrine cells in mammals. Our
findings identify a genetic requirement for formation of
late endocrine cells, establish the site where the latent
postmitotic cell type that gives rise to the endocrine
progenitor resides, and describe a novel method to
visualize morphogenetic events that occur during islet
formation.
Sources of beta cell recovery
Embryos deficient in either pdx1 or hb9 alone display an
initial decrease in ins expression, followed by restoration
of some ins-expressing cells by 5 dpf. We show here
that in double morphants such a recovery does not
occur, and define pdx1 and hb9 dependent steps in the
generation and differentiation of two distinct endocrine
cell populations arising in the early and late embryo.
The early appearance of NeuroD:EGFP-expressing islet
cells demonstrated that committed, first wave endocrine
cells of the dorsal bud were specified despite the
absence of hb9 and/or pdx1.B yc o n t r a s t ,s e c o n dw a v e
endocrine cells strictly depend on pdx1. The apparent
recovery of beta cells in pdx1 morphants thus results
from delayed differentiation of early arising, dorsal bud-
derived endocrine precursors in conditions of severely
reduced Pdx1. Since we have detected hb9 in ventral
bud-derived beta cells (D Mayer, RA Kimmel, unpub-
lished results), and Hb9 knockout causes global beta cell
deficits in mouse, delayed beta cell differentiation in hb9
morphants can be explained by restoration of protein
function due to dilution of morpholino at the time
when late endocrine cells emerge.
Progenitors for late endocrine cell expansion
During organ development, progenitors are often set
aside during the early stages to undergo later expansion
and differentiation. In prior studies of beta cell prolifera-
tion during zebrafish embryogenesis using nucleotide
analogs or proliferating cell nuclear antigen (PCNA)
antibody, dividing beta cells were detected only very
rarely or not at all [3,6,18,36,37]. To analyze and define
the proliferative status of cells generating the late-arising
endocrine cells, we used a protocol in which embryos
were exposed to a long pulse of EdU covering the time
window when late endocrine cells start emerging (from
28 to 76 hpf). This captures all cell divisions and also
labels cells that proliferate prior to endocrine
Figure 7 Schematic of Notch-responsive progenitors. In wild-
type embryos (top), an early pancreatic progenitor (yellow) gives
rise to early endocrine cells (green) as well as progenitors for late
endocrine cells (white) located in the extrapancreatic duct (EPD)
and pancreatic tail. Notch signaling maintains these latent
progenitors in an undifferentiated state. Inhibition of Notch
signaling by treatment with N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-
phenylglycine t-butyl ester (DAPT) (center) activates differentiation
of the latent progenitors, leading to new endocrine cell formation
in the principal islet and pancreatic tail (red arrows). In pdx1
morphants (bottom), early endocrine specification occurs but
Notch-responsive progenitors for late endocrine cells are absent or
hindered in differentiation, which can be demonstrated by
treatment with DAPT.
decreased EGFP+ cells in the principal islet and virtually no posterior
EGFP+ cells are induced by DAPT (I,J). All embryos lateral view,
anterior to the left. Scale bar = 10 μM. (K) Quantitation of NeuroD:
EGFP cells induced in the pancreatic tail following DAPT treatment
in control and morphant embryos. Graphed are the mean and SD
for (n) number of embryos. P values were determined using one-
way analysis of variance (ANOVA) with Bonferroni’s post test, ***P <
0.001.
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time, we observed a higher proportion of cells that had
undergone proliferation as compared to previous stu-
dies, indicating that dividing progenitors that gave rise
to beta cells as well as the rare beta cell mitoses were
revealed. Nevertheless, the low number of EdU+ endo-
crine precursors and beta cells that we detected in nor-
mal development shows that the vast majority of late
arising endocrine cells (appearing between 28 hpf and
76 hpf) have not undergone mitosis during the labeling
period. Therefore, these cells differentiate directly from
a precursor with low proliferative activity. Similarly, in
the pdx1 morphant, proliferating beta cells or mitotic
progenitors contribute only a minor fraction to the beta
cells emerging after 28 hpf.
These studies indicate that, during normal develop-
ment, the cell type that gives rise to late endocrine cells
represents a subtype of ventral bud cells that is already
set aside at 28 hpf, and that slowly divides in contrast to
the rapidly dividing cells that form the exocrine pan-
creas. Previous analysis showed that the ventral pancrea-
tic bud contains ptf1a-expressing cells that form the
exocrine pancreas and a distinct population that
responds to Notch and gives rise to endocrine and duct
cells [5]. Our data indicates that within the non-exo-
crine cells, there is a population of non-proliferative
cells that comprises latent endocrine progenitors.
Function of Pdx1 in late endocrine cells
A major finding of this work is the requirement for
pdx1 in specification of all late forming endocrine cells.
Expression of Pdx1 is very dynamic in the developing
pancreas and genetic analyses using conditional and
hypomorphic Pdx1 mutant alleles in mouse have already
indicated that Pdx1 is important in various specification
and differentiation events [38-41]. In zebrafish, fate-
mapping studies indicated that a spatial separation of
the future pancreatic DB versus VB progenitors is
already established shortly after gastrulation (10 hpf)
[42,43]. Medium levels of pdx1 expression during early
somitogenesis (10 to 15 hpf) correlate with VB fate spe-
cification [44]. Thus, already these early differences in
pdx1 expression could provide permissive or instructive
cues for the specification of latent progenitors that later
give rise to second wave endocrine cells.
The developing extrapancreatic duct and the proximal
pancreas express high levels of Pdx1 from 48 hpf ([32]
and this study). In pdx1 morpholino-treated embryos,
Pdx1 is diminished at least until 3 dpf, but overall for-
mation of the extrapancreatic duct is not affected. An
absence of duct-associated progenitors for second wave
endocrine cells could result from duct cells being com-
mitted to a non-endocrine fate due to an early defi-
ciency in Pdx1. Alternatively, deficient Pdx1 in duct
cells might impede the generation of endocrine precur-
sors from a latent progenitor. Several lines of research
suggests that pancreatic ductal epithelium is heteroge-
neous and contains a limited numbers of cells that have
the potential for endocrine differentiation [45]. We have
here defined a strategy that eliminates endocrine cell
formation without affecting duct morphology, which will
be useful to help further characterize the latent progeni-
tor cell type.
Morphogenesis of late endocrine cells
Our transgenic and timelapse analyses provide new
insights into the behavior of late-arising endocrine cells.
NeuroD:EGFP-positive cells associated with the extrapan-
creatic duct defined by 2F11 antibody staining exhibited
protrusions characteristic of delaminating cells. We devel-
oped a method for maintaining embryo viability after yolk
removal, which allowed for the first time a clear visualiza-
tion of developing late endocrine cells in living embryos.
We delineated pancreatic progenitors in the context of the
pancreatic duct and digestive system, and recorded migra-
tion of NeuroD:EGFP positive endocrine progenitors as
they emerged from the duct and moved to the principal
islet. This method provides the basis for future analysis of
molecular regulators of these complex morphogenetic
events during pancreatic islet development.
Conclusions
These studies establish that pdx1 is essential for gener-
ating an endocrine cell progenitor population associated
with the pancreatic duct in zebrafish. We show that for-
mation of latent progenitors in the extrapancreatic and
intrapancreatic duct requires pdx1, and provide evidence
that they are slowly dividing cells, and are thus distinct
from rapidly proliferating cells that form the exocrine
tissue. Further, these latent progenitors differentiate in
response to Notch inhibition. Our findings open up new
approaches for examination of the specification and
behavior of endocrine progenitors during zebrafish
embryogenesis, in which these processes can now be
visualized, and where large-scale chemical and pharma-
cologic screening can be applied. This can in turn pro-
vide clues as to how developmental programs can be
harnessed and reactivated to generate replacement beta
cells for more efficient treatment of diabetes.
Methods
Zebrafish transgenic lines
The following transgenic lines were used: Tg(ins:dsRed)
m1018 (generous gift of Wolfgang Driever, University of
Freiburg, Germany), Tg(ela3l:EGFP)gz2 [35]; TgBAC
(NeuroD:EGFP)nl1 [30]; Tg(-3.5nkx2.2a:GFP)ia3 [34]; Tg
(-8.0cldnb:lynEGFP)zf106 [46]. Zebrafish (Danio rerio)
were maintained according to standard protocols.
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The following previously validated morpholinos, targeted
against the initiation codon of pdx1 and hb9, respec-
tively, were obtained from Gene Tools (Philomath, OR,
USA): pdx1MO: 5’-GATAGTAATGCTCTTCCCGATT-
CAT-3’ [18,19]; hb9MO: 5’-TTTTTAGATTTCTC-
CATCTGGCCCA-3’ [20].
Each morpholino was prepared at a concentration of
1.5 mM. This solution was diluted to 750 μM in water
and 2 to 8 ng of morpholino in a volume of approxi-
mately 1.5 nl was injected into one-cell stage embryos.
In generating double morphants, the concentration of
individual morpholinos was halved to keep the total
amount of morpholino injected the same as for single
morphants.
In situ hybridization
Whole mount in situ hybridization was performed as
described [47]. Digoxigenin antisense probes (Roche,
Vienna, Austria) were synthesized for insulin [48]. As pre-
cise cell counting in older embryos becomes difficult with
increasing cell numbers in a tight cluster, embryos with
cell count > 5 were grouped together for quantitation.
Antibody staining
Embryos were fixed in 4% paraformaldehyde (PFA) at 4°C
(2 h to overnight, depending on stage) followed by protei-
nase K (Carl Roth, Karlsruhe, Germany) digestion (10 μg/
ml in phosphate-buffered saline (PBS)), post fixation in 4%
PFA, and incubation in blocking buffer containing 1%
bovine serum albumin (BSA, AppliChem, Darmstadt, Ger-
many), 2% Sheep serum (Sigma, Vienna, Austria), 1% Tri-
ton, and 1% dimethylsulfoxide (DMSO). Primary antibody
was diluted in blocking buffer followed by overnight incu-
bation at 4°C. Embryos were washed in PBS/BSA/Triton,
and incubated overnight at 4°C in secondary antibody
diluted 1:1,000 in blocking buffer, followed by extensive
washing in PBST (PBS + 0.1% Tween 20). Primary antisera
and dilutions were: guinea pig anti-insulin (1:200, Dako,
Vienna, Austria), rabbit anti-glucagon (1:200, Dako), rabbit
anti-pan-cadherin (1:500, Sigma), mouse anti-2F11 (1:100,
generous gift from Julian Lewis, London Research Insti-
tute, UK), rabbit anti-somatostatin (1:200, Dako), rabbit
anti-carboxypeptidase A (1:200, Chemicon, Vienna, Aus-
tria), mouse anti-GFP (1:200, Roche), rabbit anti-GFP
(1:200, Torrey Pines Biolabs, East Orange, NJ, USA), gui-
nea pig polyclonal anti-Pdx1 (1:200, generous gift from
Chris Wright, Vanderbilt University, TN, USA). Alexa-
conjugated secondary antibodies (1:1,000 dilution) were
from Invitrogen (Lofer, Austria).
Cell labeling with EdU
EdU staining was performed as previously described
[37]. In brief, reagents for the Click-iT EdU Alexa Fluor
647 Assay (Invitrogen) were prepared according to man-
ufacturer’s protocol. Embryos were incubated in 0.5 mM
EdU/0.4% DMSO in egg water (0.3 g/L Red Sea Coral
Pro Salt in reverse osmosis H2O) followed by fixation in
4% PFA. Embryos were then washed in PBST, dehy-
drated with a methanol wash, and incubated in metha-
nol at -20°C for 2 h. For the detection assay, larvae were
rehydrated through a methanol series into PBST and
manually deyolked. The larvae were treated with protei-
nase K (10 μg/ml) for 45 min, refixed in 4% PFA for 20
min, washed in PBST, and permeabilized in 1% DMSO/
0.5% Triton/PBS. Incubation in Click-iT reaction cock-
tail was performed for 2 h at room temperature fol-
lowed by rinses in PBST. Following the EdU detection
reaction, larvae were incubated in blocking buffer and
immunostaining was performed as described above.
Microscopy
Tg(ins:dsRed)m1018 and TgBAC(NeuroD:EGFP)nl1
embryos for direct fluorescence imaging were fixed in
4% PFA at room temperature for 1 to 2 h (48 hpf and
younger) or 2 to 3 h (older than 48 hpf), rinsed three
times with PBST followed by manual yolk removal.
Transgene and antibody immunostaining were imaged
with a Zeiss LSM5 Exciter (Carl Zeiss, Vienna, Austria)
confocal laser microscope, using a 40 × water immer-
sion objective. Stacks of optical sections were recorded
with a z-step ranging from 1 to 2 μm. Larvae for live
imaging were anesthetized using 1 × Tricaine mesylate
(0.003%, Sigma), immobilized in low melt agarose (1.5%,
Biozym, Vienna, Austria) and imaged on a Leica
DM6000B microscope (Leica Microsystems, Vienna,
Austria) equipped with a SPOT-RT3 digital camera
(Diagnostic Instruments, Inc., Sterling Heights, MI,
USA), using a 20 × water objective. Fluorescence stack
and differential interference contrast (DIC) images were
captured using Visiview software (Visitron Systems,
Puchheim, Germany). Fluorescence brightfield compo-
site images were prepared with ImageJ (http://rsbweb.
nih.gov/ij).
Confocal timelapse analyses
Imaging of dorsal bud cell migration at 19 hpf was per-
formed as previously described [37]. For timelapse ima-
ging of older embryos, 3 dpf embryos were anesthetized
with 1 × Tricaine mesylate diluted in egg water, then
the yolk cell was paralyzed by injection of 40 mM
AMP-PNP (adenosine 5’ (b,g-imido)triphosphate, Sigma)
and gently extruded using a tungsten needle followed by
separation of ventral membranes to expose digestive
tract and pancreas. Embryos were mounted dorsal side
down in 1.5% low-melt agarose and covered with L-15
medium (Invitrogen) diluted to 67% with sterile water,
and supplemented with penicillin/streptomycin cocktail
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Chem) and 1 × Tricaine mesylate. Embryos were imaged
for 5 to 10 h in a temperature-controlled room at 28°C.
Images were collected every 5 min, a total z-stack of 60
to 70 μm was acquired with a slice interval of 2.5 to 3.5
μM. Images were captured using a 40 × water objective
on a Zeiss LSM Exciter5 equipped with Zen 2008 soft-
ware (Carl Zeiss), followed by processing and assembly
of still images and videos using LSM Image Browser
(Carl Zeiss) and ImageJ.
Quantitative image analysis
NeuroD cell numbers in 24 hpf to 3 dpf embryos were
quantitated using Imaris 7.1.1 software (Bitplane, Zurich,
Switzerland). The spot detection algorithm was applied
to three-dimensional reconstructions of samples to iden-
tify cells using a spot size of 3 to 4 μm. Spots were fil-
tered, confirmed and edited by visual inspection, and
cell counts transferred to Prism (GraphPad Software, La
Jolla, CA, USA) for statistical analyses. For proliferation
analyses, spot detection was similarly performed for
EdU+ and NeuroD+ cells, double labeling of cells was
determined using the ‘colocalize spots’ function of
Imaris with a threshold value of 3 μm.
DAPT treatment
DAPT (Sigma) was prepared as a 10 mM stock solution
in DMSO. Larvae were incubated in DAPT diluted to
100 μM in egg water starting at 3 dpf for 48 h. The
DAPT solution was replaced after 24 h. The embryos
were then rinsed in egg water and incubated an addi-
tional 12 h. Control embryos were incubated in 1%
DMSO in egg water.
Additional material
Additional file 1: Exocrine pancreas development in hb9/pdx1
double morphants. Confocal image projection of the pancreas of 4
days post fertilization (dpf) embryos immunostained for
carboxypeptidase A (Cpa) and insulin (Ins). hb9/pdx1 double morphant
embryos (B) with severely reduced Ins (insets, (A), compared to B), show
Cpa expression comparable to control embryos (A). All are in
ventrolateral view. Scale bar = 30 μM.
Additional file 2: Pdx1 protein expression in pdx1 morphants.
Confocal projections of control and pdx1 morpholino-injected embryos
at 28 h post fertilization (hpf) (A-C) and 48 hpf (D-F), immunostained for
Pdx1. (A-C) Control embryos express Pdx1 in the developing gut and
pancreas. (D-F) pdx1 morphant embryos have no detectable Pdx1
expression. (B,E) Overlay of bright field with confocal projection of Pdx1
antibody staining, (C,F) single channel showing Pdx1 antibody. Dashed
circle (E) indicates islet as determined from bright field images. Non-
specific labeling by this antibody of somites lateral to the gut (asterisks)
has been previously described [49]. Ventral view. Scale bar = 10 μM.
Confocal projections (G,H) and single plane views (I-L) of control and
pdx1 morphants at 84 hpf, immunostained for Pdx1 and
carboxypeptidase A (Cpa) to indicate the exocrine pancreas. Control
embryos show robust Pdx1 expression in the islet and weaker expression
in the exocrine pancreas (G,I,K). pdx1 morphant embryos have low-level
Pdx1 expression in the islet and exocrine pancreas (H,J,L). Lateral view,
anterior to left. Scale bar = 30 μM.
Additional file 3: NeuroD: enhanced green fluorescent protein
(EGFP) cells are endocrine precursors. (A) TgBAC(NeuroD:EGFP)nl1
embryos, mounted dorsal side up, imaged by confocal timelapse
microscopy starting at 19 h post fertilization (hpf). Images were captured
every 15 min. Asterisks indicate fixed points of the embryo determined
from the bright field image. Anterior is to the left. (B-G) Confocal image
projection of 24 hpf TgBAC(NeuroD:EGFP)nl1 embryo immunostained for
green fluorescent protein (GFP) and insulin (Ins) (B-D) and GFP and
somatostatin (Sst) (E-G), showing overlap of NeuroD:EGFP expression
with islet hormones in a subset of cells. All are ventral view. Scale bar =
15 μM.
Additional file 4: Migration of early endocrine cells. Confocal
timelapse imaging of TgBAC(NeuroD:EGFP)nl1 embryo beginning at 19 h
post fertilization (hpf). Confocal stacks were collected every 15 min.
Dorsal view, anterior to the left. Still images from this file were used in
Additional file 3A.
Additional file 5: Additional table 1. NeuroD: enhanced green
fluorescent protein (EGFP) cells at 28 h post fertilization (hpf) in control,
hb9- and pdx1- morphants.
Additional file 6: Larval NeuroD:EGFP and Pdx1 expression. Confocal
projections (A,D) and single plane views (B,C,E,F) of control (A-C) and
pdx1 morpholino injected (D-F) TgBAC(NeuroD:EGFP)nl1 embryos at 5
days post fertilization (dpf), immunostained for Pdx1 and green
fluorescent protein (GFP). (A-C) In control embryos, robust Pdx1
expression in the islet overlaps with GFP. (D-F) pdx1 morphant embryos
have reduced Pdx1 expression and GFP+ cells in the islet as compared
to control. Lateral view, anterior to left. Scale bar = 10 μM.
Additional file 7: Beta cell differentiation and duct development. (A,
B) Single plane, ventral view of TgBAC(NeuroD:EGFP)nl1;Tg(ins:dsRed)
m1018 control embryo at 72 h post fertilization (hpf). With the red
channel overexposed, anterior enhanced green fluorescent protein
(EGFP)+ cells with low levels of InsDsRed can be detected (arrow). (C)
Confocal projection of TgBAC(NeuroD:EGFP)nl1 embryo at 72 hpf
immunostained for green fluorescent protein (GFP) and insulin (Ins). The
Ins signal is overexposed to show low-expressing cells anterior to the
principal islet. Scale bar = 10 μM. (D-G) Confocal projection of 84 hpf Tg
(-3.5nkx2.2a:GFP)ia3 embryos immunostained for GFP and Ins. GFP
expression delineates developing duct in control (D,F), and pdx1
morphant (E,G) embryos. EPD, extrapancreatic duct; IPD, intrapancreatic
duct. Ventral view. Scale bar = 15 μM. (H-K) Single plane views of 72 hpf
Tg(-8.0cldnb:lynEGFP)zf106 embryos immunostained for Pdx1 and GFP.
Control embryos show robust Pdx1 expression in the proximal pancreas
and EPD (H,J), as compared to weak expression in pdx1 morphants (I,K).
(J) and (K) represent the red channel only from (H) and (I). Ventral view,
anterior to left. Scale bar = 10 μM.
Additional file 8: NeuroD:enhanced green fluorescent protein
(EGFP) cells migrate from duct to islet. Timelapse confocal series of a
3 days post fertilization (dpf) TgBAC(NeuroD:EGFP)nl1;Tg(-8.0cldnb:lynEGFP)
zf106 embryo imaged for 6 h from a ventral view with yolk removed.
Images were collected every 5 min. Migrating cells are indicated by
arrows in the initial frames. Still images from this file were used in Figure
4E.
Additional file 9: Proliferation during exocrine pancreas formation.
Tg(ela3l:EGFP)gz2 [35] embryos labeled with EdU from 24 to 72 h post
fertilization (hpf), and fixed at 84 hpf. EdU detection (blue) was followed
by antibody staining to label Elastase (Ela)-expressing exocrine cells (Ela:
green fluorescent protein (GFP), green) and beta cells (insulin (Ins), red).
(A,C) Three-dimensional confocal projections showing composite of Ela:
GFP, EdU and Ins in control (A), and pdx1 morphant embryos (C) at 84
hpf. EdU labels exocrine pancreas extensively in control and morphants.
(B,D) Single plane views of embryos as in (A) and (C), showing rare cells
with EdU/Ins colabeling (arrow). For clarity, the GFP channel is not
shown. (E) Quantitation of EdU/Ins colabeled cells per embryo in control
and pdx1 morphant embryos, showing mean and standard deviation. NS,
not significant; P > 0.05 as determined by unpaired t test. Anterior is to
the left. Scale bar = 15 μm.
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Page 12 of 14Additional file 10: Larval duct morphology. Confocal projection of 6
days post fertilization (dpf) TgBAC(NeuroD:EGFP)nl1 embryos
immunostained for green fluorescent protein (GFP) and 2F11. In control
embryos (A), 2F11 positive cells surround GFP+ islet cells and extend
into the pancreatic tail. Single NeuroD+ cells can be found in the
pancreas tail (arrow). (B) pdx1 morphant embryos, with fewer GFP+ cells
in the islet, have similar 2F11 expression around the islet and in the
pancreatic tail (arrows). Lateral view. Scale bar = 30 μM.
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